The drop comes after BNB hit a record high near $860, driven by aggressive moves into the token by public companies.

Windtree Therapeutics, recently made waves by announcing plans to allocate up to $700 million toward acquiring BNB.

Windtree said it aims to become the first NASDAQ-listed company to offer direct exposure to BNB. The treasury strategy ...

Biotech firm Windtree plans $520M Binance Coin bet via stock deals and credit line, pending shareholder approval amid mixed ...

BNB/USDhits a fresh all-time high on positive developments. It hits a high of $855 and is currently trading around $851.50.

About Windtree Therapeutics, Inc. Windtree Therapeutics, Inc. is a diversified company with several divisions, including a cryptocurrency treasury strategy and two promising therapeutic pipelines for ...

Windtree Therapeutics has said it is raising another $520 million to buy up BNB, the fifth-largest digital coin, to put on ...

The rebound was fueled by Windtree Therapeutics' commitment to invest $520 million in BNB for its corporate treasury.

Crypto exchange Kraken will custody and manage BNB assets for Windtree Therapeutics' crypto treasury plan tied to Binance ...

Windtree Therapeutics, a Nasdaq listed biotechnology company, has plans to raise up to $200 million to build a treasury of ...

Windtree Therapeutics' latest move goes beyond its surprising forays into real estate and waste management, as the company ...

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) recently announced its financial results for the second quarter ending June 30, 2024, along with significant business updates. The ...